Patients with COVID-19 who have modified high-risk obstructive sleep apnea (OSA) are at increased risk for delayed clinical improvement compared with patients who have modified low-risk OSA.
In patients with COPD, lockdown for coronavirus disease 2019 (COVID-19) was associated with a reduction in exacerbations and an improvement in symptoms.
Disease severity of both chronic obstructive pulmonary disease (COPD) and asthma may increase the risk of the development of severe coronavirus disease 2019 (COVID-19).
Researchers compared IL-1 and IL-6 inhibition vs standard management in hospitalized patients with COVID-19, respiratory insufficiency, and hyperinflammation.
Compared with the absence of asthma, the presence of asthma is associated with a comparable risk of hospitalization and use of mechanical ventilation, and a lower risk of mortality in patients with COVID-19.
In patients with asthma, the presence of preexisting eosinophilia was protective against coronavirus disease 2019 (COVID-19)-associated hospital admission.
Researchers identified risk factors for serious infections in rheumatoid arthritis and validated the RABBIT risk score in real-life settings.
The COVID-19 Reporting and Data System (CO-RADS) in combination with a CT severity score are easy to use diagnostic tools to guide clinicians in diagnosing COVID-19.
In hospitalized patients with COVID-19, the routine use of molecular point-of-care testing in emergency department admissions was associated with a large reduction in time to results compared with laboratory PCR testing.
In patients with COVID-19 admitted to the ICU with a high acuity of illness and a prolonged period of mechanical ventilation, the time to start rehabilitation was often delayed because of the severity of an individual’s condition.
